Literature DB >> 15194666

Remarkable difference in the mode of HCV transmission among haemodialysis patients and IVDAs.

S M Alavian, B Hajarizadeh.   

Abstract

Entities:  

Mesh:

Year:  2004        PMID: 15194666      PMCID: PMC1774097     

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  7 in total

1.  Triple infection with human immunodeficiency virus, hepatitis C virus, and hepatitis B virus: a clinical challenge.

Authors:  Richard K Sterling
Journal:  Am J Gastroenterol       Date:  2003-10       Impact factor: 10.864

2.  Rapid spread of hepatitis C and needle exchange programme in Kolkata, India.

Authors:  K Sarkar; S Mitra; B Bal; S Chakraborty; S K Bhattacharya
Journal:  Lancet       Date:  2003-04-12       Impact factor: 79.321

Review 3.  Transmission of hepatitis C virus: rates, routes, and cofactors.

Authors:  M MacDonald; N Crofts; J Kaldor
Journal:  Epidemiol Rev       Date:  1996       Impact factor: 6.222

4.  Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.

Authors:  R S Garfein; D Vlahov; N Galai; M C Doherty; K E Nelson
Journal:  Am J Public Health       Date:  1996-05       Impact factor: 9.308

5.  Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program.

Authors:  H Hagan; D C Jarlais; S R Friedman; D Purchase; M J Alter
Journal:  Am J Public Health       Date:  1995-11       Impact factor: 9.308

6.  Recommendations for preventing transmission of infections among chronic hemodialysis patients.

Authors: 
Journal:  MMWR Recomm Rep       Date:  2001-04-27

7.  Mode of hepatitis C infection not associated with blood transfusion among chronic hemodialysis patients.

Authors:  K Okuda; H Hayashi; S Kobayashi; Y Irie
Journal:  J Hepatol       Date:  1995-07       Impact factor: 25.083

  7 in total
  1 in total

1.  Intrafamily transmission of HCV need to more discussion.

Authors:  S M Alavian
Journal:  Iran Red Crescent Med J       Date:  2011-01-01       Impact factor: 0.611

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.